Myeloperoxidase (MP) quantity research in neutrophils (NP) and their size in 29 almost healthy donors and 124 newly diagnosed destructive pulmonary tuberculosis patients before the beginning of treatment and after carrying out a therapy during one month was conducted. Patients were divided into 2 groups: 1st group — the patients who obtained a standard antituberculous therapy (SAT), 2nd group — besides standard therapy, corvitin was prescribed. Tuberculosis patients had NP activation. Treatment in comparison group had no influence on morphofunctional NP activation. Addition of corvitin to SAT was explained by cytoplasma optical density increasing when MP painting against a background of reliable decreasing or tendency to NP size decreasing.
